This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Neurogenetics  • Neurology, Other  • Radiologic Imaging  • Magnetic Resonance Imaging  • Genetic Counseling/ Testing/ Therapy  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Stefania Battistini, MD, PhD; Raffaele Rocchi, MD; Alfonso Cerase, MD; Alberto Citterio, MD; Laura Tassi, MD; Giuliana Lando, MS; Maria Cristina Patrosso, MS; Rosita Galli, MD; Paola Brunori, MD; Domenica L. Sgrò, MD; Giovanni Pitillo, MD; Giorgio Lo Russo, MD; Alessandro Marocchi, MD; Silvana Penco, MS, PhD

Arch Neurol. 2007;64(6):843-848.

Background  Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in seizures, hemorrhage, recurrent headaches, and focal neurologic deficits. These CCMs can occur as sporadic or autosomal dominant conditions, although with incomplete penetrance and variable clinical expression. Three CCM loci have been identified, on chromosomes 7q21-22 (CCM1; Online Mendelian Inheritance in Man [OMIM] 116860), 7p13-15 (CCM2; OMIM 603284), and 3q25.2-27 (CCM3; OMIM 603285), and 3 genes have been cloned, KRIT1 on CCM1, MGC4607 on CCM2, and PDCD10 on CCM3. Mutations in KRIT1 account for more than 40% of CCMs.

Objective  To describe the results of a comprehensive evaluation of 5 Italian families affected with CCM.

Design  Clinical, magnetic resonance imaging, and KRIT1 gene analysis.

Setting  University academic teaching hospitals.

Patients  Fifteen patients with CCM diagnosed according to defined criteria and 45 at-risk, symptom-free relatives.

Results  Three novel and 2 described mutations were found in KRIT1. The families included 33 KRIT1 mutation carriers, 57.6% of whom had no symptoms. Magnetic resonance imaging revealed CCM lesions in 82.3% of symptom-free mutation carriers.

Conclusions  The data confirm both incomplete clinical and neuroimaging penetrance in families with the KRIT1 mutation. This consideration is important in genetic counseling. Moreover, the data emphasize both the importance of magnetic resonance imaging in the diagnosis of CCM and the potential for DNA-based diagnosis to identify subjects at risk.

Author Affiliations: Department of Neuroscience, Neurology Section, University of Siena (Drs Battistini, Rocchi, and Galli), and Department of Neurosciences, Unit of Diagnostic and Therapeutic Neuroradiology, Azienda Ospedaliera Universitaria Senese (Dr Cerase), Siena, Italy; Departments of Neuroradiology (Dr Citterio) and Neuroscience, Regional Centre for Epilepsy Surgery (Drs Tassi and Lo Russo), and Clinical Chemistry and Clinical Pathology Laboratory, Medical Genetics (Mss Lando and Patrosso and Drs Marocchi and Penco), A. O. Niguarda Ca’Granda Hospital, Milan, Italy; Neurofisiopatology, A. O. Silvestrini, Perugia, Italy (Dr Brunori); Department of Pediatric Sciences, Child Neuropsychiatry Unit, AOU Policlinico "G. Martino," Messina, Italy (Dr Sgrò); and Child Neuropsychiatry Unit, "F. del Ponte" Hospital, University of Insubria, Varese, Italy (Dr Pitillo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immune Response in Human Cerebral Cavernous Malformations
Shi et al.
Stroke 2009;40:1659-1665.
ABSTRACT | FULL TEXT  

Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2
Mittal et al.
Am. J. Neuroradiol. 2009;30:232-252.
ABSTRACT | FULL TEXT